HC Wainwright Lowers MacroGenics (NASDAQ:MGNX) Price Target to $2.00
MacroGenics (NASDAQ:MGNX – Free Report) had its price objective cut by HC Wainwright from $4.00 to $2.00 in a research note released on Tuesday morning,Benzinga reports. They currently have a neutral rating on the biopharmaceutical company’s stock. Separately, StockNews.com downgraded MacroGenics from a “buy” rating to a “hold” rating in a research report on Friday, […]
MacroGenics (NASDAQ:MGNX – Free Report) had its price objective cut by HC Wainwright from $4.00 to $2.00 in a research note released on Tuesday morning,Benzinga reports. They currently have a neutral rating on the biopharmaceutical company’s stock. Separately, StockNews.com downgraded MacroGenics from a “buy” rating to a “hold” rating in a research report on Friday, […]
